Carlo Garufi

Summary

Country: Italy

Publications

  1. pmc Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial
    C Garufi
    Department of Medical Oncology, Regina Elena Cancer Institute, Rome, Italy
    Br J Cancer 103:1542-7. 2010
  2. ncbi Randomised phase II study of standard versus chronomodulated CPT-11 plus chronomodulated 5-fluorouracil and folinic acid in advanced colorectal cancer patients
    Carlo Garufi
    Department of Medical Oncology, Istituto Regina Elena, Via Chianesi, 53, 00144 Rome, Italy
    Eur J Cancer 42:608-16. 2006
  3. doi Validation of patient's self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients: results of an international study by the Chronotherapy Group of the European Organisation for Research and
    Fabio Efficace
    Italian Group for Adult Hematologic Diseases GIMEMA, GIMEMA Data Center, Health Outcome Research Unit, via Benevento, 6, 00161, Rome, Italy
    J Clin Oncol 26:2020-6. 2008
  4. pmc An integrated psychological strategy for advanced colorectal cancer patients
    Patrizia Pugliese
    Service of Psychology, Regina Elena Cancer Institute, Via Elio Chianesi, 53, 00144 Rome, Italy
    Health Qual Life Outcomes 4:9. 2006
  5. pmc Decrease of survivin, p53 and Bcl-2 expression in chemorefractory colorectal liver metastases may be predictive of radiosensivity radiosensivity after radioembolization with yttrium-90 resin microspheres
    Elisa Melucci
    Department of Pathology, Regina Elena National Cancer Institute, Rome, Italy
    J Exp Clin Cancer Res 32:13. 2013
  6. ncbi Weekly docetaxel in pretreated metastatic breast cancer patients: a phase I-II study
    Cecilia Nistico
    Department of Medical Oncology, Regina Elena National Cancer Institute, Roma, Italy
    Oncology 68:356-63. 2005
  7. pmc Epidermal growth factor receptor gene copy number in 101 advanced colorectal cancer patients treated with chemotherapy plus cetuximab
    Carla Campanella
    Department of Medical Oncology, Regina Elena Institute, Rome, Italy
    J Transl Med 8:36. 2010
  8. ncbi Hepatic arterial infusion (HAI) of cisplatin and systemic fluorouracil in the treatment of unresectable colorectal liver metastases
    Raffaello Mancini
    Department of Surgical Oncology, Regina Elena Cancer Institute, Via Elio Chianesi, 53, 00013 Rome, Italy
    Anticancer Res 23:1837-41. 2003
  9. ncbi Persistence of high-dose oxaliplatin-induced neuropathy at long-term follow-up
    Alberto Pietrangeli
    Department of Neurology, Regina Elena Institute, Rome, Italy
    Eur Neurol 56:13-6. 2006
  10. ncbi Primary chemotherapy with epirubicin and vinorelbine in women with locally advanced breast cancer
    Cecilia Nistico
    Department of Medical Oncology, Regina Elena National Cancer Institute, Rome, Italy
    Anticancer Res 25:1343-8. 2005

Detail Information

Publications10

  1. pmc Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial
    C Garufi
    Department of Medical Oncology, Regina Elena Cancer Institute, Rome, Italy
    Br J Cancer 103:1542-7. 2010
    ....
  2. ncbi Randomised phase II study of standard versus chronomodulated CPT-11 plus chronomodulated 5-fluorouracil and folinic acid in advanced colorectal cancer patients
    Carlo Garufi
    Department of Medical Oncology, Istituto Regina Elena, Via Chianesi, 53, 00144 Rome, Italy
    Eur J Cancer 42:608-16. 2006
    ..In conclusion, this study has shown that chronomodulated infusion of CPT-11 and FA/5-FU is safe, active and can be integrated with oxaliplatin (EORTC 05011) for the treatment of advanced colorectal cancer...
  3. doi Validation of patient's self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients: results of an international study by the Chronotherapy Group of the European Organisation for Research and
    Fabio Efficace
    Italian Group for Adult Hematologic Diseases GIMEMA, GIMEMA Data Center, Health Outcome Research Unit, via Benevento, 6, 00161, Rome, Italy
    J Clin Oncol 26:2020-6. 2008
    ..The aim of this research is to validate this model on data from an independent sample...
  4. pmc An integrated psychological strategy for advanced colorectal cancer patients
    Patrizia Pugliese
    Service of Psychology, Regina Elena Cancer Institute, Via Elio Chianesi, 53, 00144 Rome, Italy
    Health Qual Life Outcomes 4:9. 2006
    ..The aim of this report is to describe an integrated approach and to evaluate its feasibility in routine clinical practice in 98 advanced colorectal cancer (ACC) patients during chronomodulated chemotherapy...
  5. pmc Decrease of survivin, p53 and Bcl-2 expression in chemorefractory colorectal liver metastases may be predictive of radiosensivity radiosensivity after radioembolization with yttrium-90 resin microspheres
    Elisa Melucci
    Department of Pathology, Regina Elena National Cancer Institute, Rome, Italy
    J Exp Clin Cancer Res 32:13. 2013
    ..Although our analysis was conducted in a very limited number cases, these changes appear strictly related to the response to (90)Y-RE therapy and may deserve further investigation on a larger series of patients...
  6. ncbi Weekly docetaxel in pretreated metastatic breast cancer patients: a phase I-II study
    Cecilia Nistico
    Department of Medical Oncology, Regina Elena National Cancer Institute, Roma, Italy
    Oncology 68:356-63. 2005
    ..We conducted a phase I-II study to determine the maximum tolerated dose (MTD), toxicity and activity of weekly docetaxel administration in pretreated metastatic breast cancer patients...
  7. pmc Epidermal growth factor receptor gene copy number in 101 advanced colorectal cancer patients treated with chemotherapy plus cetuximab
    Carla Campanella
    Department of Medical Oncology, Regina Elena Institute, Rome, Italy
    J Transl Med 8:36. 2010
    ..Aim of this study was to assess the role of EGFR-GCN in advanced colorectal cancer (CRC) patients receiving chemotherapy plus Cetuximab...
  8. ncbi Hepatic arterial infusion (HAI) of cisplatin and systemic fluorouracil in the treatment of unresectable colorectal liver metastases
    Raffaello Mancini
    Department of Surgical Oncology, Regina Elena Cancer Institute, Via Elio Chianesi, 53, 00013 Rome, Italy
    Anticancer Res 23:1837-41. 2003
    ..Only 5-10% of colorectal cancer patients (pts) with liver metastases are eligible for surgical resection. Regional and systemic chemotherapy represents the best therapeutic options for unresectable metastases...
  9. ncbi Persistence of high-dose oxaliplatin-induced neuropathy at long-term follow-up
    Alberto Pietrangeli
    Department of Neurology, Regina Elena Institute, Rome, Italy
    Eur Neurol 56:13-6. 2006
    ..The reversibility of these effects was studied. Five patients continue to manifest symptoms and signs of neurotoxicity after a long follow-up, indicating persistence of this peculiar type of neuropathy...
  10. ncbi Primary chemotherapy with epirubicin and vinorelbine in women with locally advanced breast cancer
    Cecilia Nistico
    Department of Medical Oncology, Regina Elena National Cancer Institute, Rome, Italy
    Anticancer Res 25:1343-8. 2005
    ....